AwardedFranceGoods
UNIHA-Fourniture de Médicaments Dermatologiques et du Système Respiratoire
- Published
- Published 15 January 2026
Overview
CHU Lyon procured dermatological and respiratory system medications through a framework agreement. The contract was awarded on 3 December 2025 to four suppliers: Alliance Pharma France, Celltrion Healthcare France, GlaxoSmithKline, and Novartis Pharma, for a total value of €341,677.77.
Key details
- Country
- France
- Status
- Awarded
- Category
- Goods
- Procedure
- Selective
- Published
- 15 January 2026
Pharmaceutical productsMedicinal products for dermatologyMedicinal products for the respiratory system
Award outcome
- Awarded value
- €341,678
- Award date
- 3 December 2025
- Contract period
- 11 December 2025 → 31 May 2027
- ALLIANCE PHARMA FRANCE
- CELLTRION HEALTHCARE FRANCE
- GLAXOSMITHKLINE
- NOVARTIS PHARMA
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
15 January 2026
Contracting authority
CHU Lyon
Procuring entityLyon cedex 08, France
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.